0,849  0,005  Caspase 9 stimulant
0,794  0,005  Sensitization
0,804  0,016  Apoptosis agonist
0,800  0,015  Antiinflammatory
0,766  0,003  UGT1A4 substrate
0,769  0,009  TNF expression inhibitor
0,757  0,008  Antihypercholesterolemic
0,676  0,008  UGT1A9 substrate
0,670  0,005  UGT1A1 substrate
0,680  0,023  Antineoplastic (breast cancer)
0,659  0,011  Chemopreventive
0,640  0,004  UGT1A3 substrate
0,655  0,025  Transcription factor NF kappa B inhibitor
0,647  0,024  Antineoplastic (lung cancer)
0,628  0,012  CYP2C19 substrate
0,623  0,009  Antipruritic, allergic
0,612  0,004  Sulfotransferase substrate
0,625  0,026  CYP3A4 substrate
0,613  0,015  Chemoprotective
0,606  0,018  Cholesterol antagonist
0,605  0,020  CYP2C9 substrate
0,583  0,003  Neurotrophic factor enhancer
0,586  0,009  UGT1A6 substrate
0,593  0,018  Respiratory analeptic
0,581  0,013  Antineoplastic (pancreatic cancer)
0,575  0,021  Prostate cancer treatment
0,550  0,005  UGT2B4 substrate
0,543  0,003  TRPA1 agonist
0,545  0,005  Anesthetic general
0,542  0,003  UGT2B7 substrate
0,549  0,014  Lipoprotein disorders treatment
0,563  0,029  Antileukemic
0,546  0,015  NOS3 expression inhibitor
0,538  0,008  Antihypoxic
0,546  0,015  AR expression inhibitor
0,532  0,002  UGT2B9 substrate
0,540  0,017  Hepatic disorders treatment
0,536  0,013  Nitric oxide antagonist
0,538  0,022  Antineoplastic (ovarian cancer)
0,518  0,005  Interferon gamma antagonist
0,524  0,011  UDP-glucuronosyltransferase substrate
0,524  0,016  NOS2 expression inhibitor
0,515  0,010  Antineoplastic (endocrine cancer)
0,526  0,023  Bone diseases treatment
0,492  0,003  Antipruritic, non-allergic
0,503  0,015  Antipyretic
0,510  0,026  Vasodilator, peripheral
0,502  0,020  Antiosteoporotic
0,483  0,005  UGT2B15 substrate
0,480  0,008  Prostatic (benign) hyperplasia treatment
0,476  0,008  Hair growth stimulant
0,473  0,006  Prostate disorders treatment
0,498  0,033  Teratogen
0,489  0,024  Analeptic
0,485  0,022  Apoptosis antagonist
0,475  0,015  Hypolipemic
0,485  0,027  Cytotoxic
0,468  0,012  Antihelmintic
0,462  0,008  Contraceptive
0,455  0,003  Contraceptive female
0,467  0,018  Antiparasitic
0,461  0,014  Antineoplastic (liver cancer)
0,451  0,004  Antiinfertility, female
0,455  0,009  Anesthetic
0,472  0,027  Antineoplastic (melanoma)
0,450  0,009  Abortion inducer
0,468  0,034  Embryotoxic
0,459  0,028  Antipsoriatic
0,456  0,026  Antioxidant
0,427  0,008  Antiacne
0,449  0,034  CYP2D6 substrate
0,424  0,011  Sodium/bile acid cotransporter inhibitor
0,471  0,059  Cyclophilin D inhibitor
0,471  0,059  Antidiabetic
0,442  0,032  Caspase 3 stimulant
0,450  0,044  Antineoplastic (colorectal cancer)
0,432  0,026  Cardiovascular analeptic
0,407  0,004  Cholesterol synthesis inhibitor
0,433  0,031  Antineoplastic (cervical cancer)
0,432  0,031  CTGF expression inhibitor
0,440  0,042  Antineoplastic (colon cancer)
0,395  0,003  SULT1A1 substrate
0,433  0,047  CYP2C19 inhibitor
0,401  0,029  Proliferative diseases treatment
0,377  0,006  UGT2B1 substrate
0,397  0,032  Antineoplastic (multiple myeloma)
0,400  0,038  Cardioprotectant
0,372  0,011  Lipocortins synthesis antagonist
0,396  0,037  Antineoplastic (glioma)
0,398  0,041  ICAM1 expression inhibitor
0,389  0,033  Hypoxia-inducible factor 1 alpha inhibitor
0,421  0,066  15-Lipoxygenase inhibitor
0,359  0,006  Antifungal enhancer
0,362  0,010  Antiviral (Influenza A)
0,366  0,014  Melanin inhibitor
0,353  0,004  LDLR expression enhancer
0,365  0,018  Non-steroidal antiinflammatory agent
0,404  0,061  Immunosuppressant
0,354  0,018  Hepatoprotectant
0,353  0,018  Antiviral (Influenza)
0,337  0,005  ABCA1 expression enhancer
0,354  0,023  Growth hormone agonist
0,335  0,011  Interleukin 6 antagonist
0,361  0,043  Calcium channel activator
0,322  0,005  Potassium channel (Ca-activated) activator
0,366  0,050  12-Lipoxygenase inhibitor
0,367  0,055  Antifungal
0,319  0,008  SULT1A3 substrate
0,315  0,004  Potassium channel large-conductance Ca-activated activator
0,315  0,007  Androgen antagonist
0,327  0,018  Gastrin inhibitor
0,310  0,004  UGT2B10 substrate
0,310  0,005  Farnesoid X receptor antagonist
0,377  0,075  Antiobesity
0,329  0,034  Sigma receptor agonist
0,304  0,010  Endometrios treatment
0,313  0,020  Diuretic
0,324  0,033  Antihypertriglyceridemic
0,363  0,072  Stroke treatment
0,335  0,044  Antiprotozoal (Leishmania)
0,327  0,041  Carcinogenic
0,337  0,055  Radioprotector
0,313  0,034  Antineoplastic enhancer
0,332  0,054  Interleukin 2 agonist
0,319  0,042  Vascular (periferal) disease treatment
0,296  0,020  Protein-tyrosine phosphatase inhibitor
0,275  0,004  Keratolytic
0,289  0,020  Lipid peroxidase inhibitor
0,314  0,048  Tumour necrosis factor alpha release inhibitor
0,287  0,021  Antihelmintic (Nematodes)
0,323  0,059  CYP1A2 substrate
0,287  0,025  Antiseptic
0,311  0,049  Transcription factor STAT inhibitor
0,269  0,008  Retinoprotector
0,321  0,062  Spasmolytic
0,260  0,006  Aromatase inhibitor
0,258  0,006  Estrogen receptor alpha antagonist
0,253  0,005  Arachidonic acid antagonist
0,301  0,053  Transcription factor STAT3 inhibitor
0,293  0,045  Antiulcerative
0,251  0,004  5-Alpha-reductase inhibitor
0,261  0,015  Protein-tyrosine phosphatase 1B inhibitor
0,341  0,095  Atherosclerosis treatment
0,286  0,040  Antiparkinsonian, rigidity relieving
0,250  0,005  Actinic keratosis treatment
0,248  0,004  Adenylate cyclase stimulant
0,247  0,006  Estrogen agonist
0,259  0,018  Heat shock protein 90 antagonist
0,240  0,003  Liver X receptor alpha agonist
0,239  0,004  Antiviral (Coronavirus)
0,239  0,004  Antiviral (SARS coronavirus)
0,287  0,054  Angiogenesis stimulant
0,236  0,004  Glutamate release inhibitor
0,296  0,065  Antidiabetic (type 2)
0,239  0,008  HDL-cholesterol increasing
0,233  0,003  SULT1A2 substrate
0,335  0,107  Histamine release inhibitor
0,288  0,062  Antineoplastic (non-small cell lung cancer)
0,288  0,062  DNA damaging
0,243  0,020  Adenylate cyclase inhibitor
0,243  0,025  Phospholipase A2 inhibitor
0,271  0,054  Antineoplastic (sarcoma)
0,235  0,020  Antihyperlipoproteinemic
0,225  0,010  Estrogen antagonist
0,296  0,083  Antineoplastic (brain cancer)
0,216  0,004  Bile acid receptor antagonist
0,288  0,079  Antineoplastic (osteosarcoma)
0,269  0,061  Free radical scavenger
0,266  0,058  Antineoplastic (glioblastoma multiforme)
0,252  0,048  RNA-directed DNA polymerase inhibitor
0,232  0,029  Skin whitener
0,205  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,228  0,028  Toxic, respiratory center
0,249  0,050  Sedative
0,319  0,122  Antibacterial
0,210  0,015  Choleretic
0,257  0,065  Cardiodepressant
0,198  0,007  CDC25A inhibitor
0,271  0,080  5 Hydroxytryptamine release stimulant
0,194  0,005  UGT2B11 substrate
0,224  0,034  Protein kinase stimulant
0,213  0,024  Psychosexual dysfunction treatment
0,199  0,011  Pregnane X receptor agonist
0,192  0,004  Glycine receptor agonist
0,226  0,038  Antiviral (Herpes)
0,188  0,005  Purinergic P2X2 antagonist
0,186  0,005  Ornithine decarboxylase inhibitor
0,207  0,026  DNA polymerase I inhibitor
0,267  0,089  Immunostimulant
0,181  0,007  Anabolic
0,252  0,079  5 Hydroxytryptamine uptake stimulant
0,177  0,005  3C-Like protease (SARS coronavirus) inhibitor
0,174  0,005  Acetyl-CoA transferase inhibitor
0,171  0,002  Heme oxygenase stimulant
0,180  0,011  Estrogen receptor beta antagonist
0,244  0,076  Acute neurologic disorders treatment
0,261  0,093  Lipoxygenase inhibitor
0,187  0,021  Growth stimulant
0,219  0,053  P-glycoprotein inhibitor
0,186  0,021  Anticataract
0,245  0,081  Antineoplastic (renal cancer)
0,162  0,003  Retinoid X alpha receptor agonist
0,200  0,043  Antiparkinsonian, tremor relieving
0,166  0,010  Tocolytic
0,242  0,085  Aldehyde oxidase inhibitor
0,207  0,052  Muscle relaxant
0,240  0,086  Interleukin agonist
0,206  0,052  Antimutagenic
0,158  0,006  Progesterone antagonist
0,163  0,011  Postmenopausal disorders treatment
0,172  0,023  Alcohol dehydrogenase substrate
0,150  0,004  Liver X receptor alpha antagonist
0,197  0,051  Antipruritic
0,209  0,066  Pneumotoxic
0,146  0,003  Retinoid X receptor agonist
0,248  0,106  Metabolic disease treatment
0,144  0,003  Liver X receptor beta antagonist
0,268  0,127  Ulceration
0,174  0,034  Antieczematic
0,166  0,026  Vanilloid 1 agonist
0,218  0,085  Antihypotensive
0,137  0,004  Liver X receptor antagonist
0,202  0,070  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,188  0,056  Eye irritation, high
0,141  0,009  Hyperparathyroidism treatment
0,181  0,049  NOS3 expression enhancer
0,224  0,093  Hypoglycemic
0,186  0,055  Phospholipase C inhibitor
0,137  0,009  Na+ K+ transporting ATPase inhibitor
0,130  0,004  Liver X receptor beta agonist
0,192  0,069  VEGF expression inhibitor
0,130  0,008  Estrogen receptor beta agonist
0,131  0,009  Androgen agonist
0,129  0,008  Estradiol 17 beta-dehydrogenase inhibitor
0,172  0,051  Antidiarrheal
0,134  0,013  Vanilloid agonist
0,152  0,032  Nav1.1 sodium channel blocker
0,124  0,004  Postcoital contraceptive
0,137  0,017  Contraceptive male
0,163  0,044  Anesthetic local
0,180  0,062  Heat shock protein 90 alpha antagonist
0,122  0,004  5-Alpha-reductase 2 inhibitor
0,126  0,009  Anticholelithogenic
0,121  0,007  Aldosterone antagonist
0,158  0,044  Monophenol monooxygenase inhibitor
0,126  0,012  Cushing's syndrome treatment
0,119  0,006  Liver X receptor agonist
0,198  0,087  Antialcoholic
0,238  0,128  CYP3A4 inhibitor
0,131  0,021  Transcription factor NF kappa B stimulant
0,117  0,011  Estrogen-related receptor beta agonist
0,123  0,017  Glycine receptor antagonist
0,151  0,046  Antihemorrhagic
0,114  0,009  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,134  0,030  Prolactin inhibitor
0,126  0,024  Interleukin 12 antagonist
0,106  0,003  Geranyltranstransferase inhibitor
0,199  0,099  Antineoplastic (lymphocytic leukemia)
0,102  0,003  Cholesterol ester transfer protein antagonist
0,142  0,044  Menstruation disorders treatment
0,104  0,007  SULT2A1 substrate
0,104  0,008  Estrogen receptor alpha agonist
0,119  0,024  Opioid kappa receptor antagonist
0,111  0,017  Narcotic antagonist
0,121  0,029  SULT1E1 substrate
0,113  0,021  Lipase inhibitor
0,147  0,055  Cocaine dependence treatment
0,141  0,050  Skin irritative effect
0,095  0,005  Adenylate cyclase 1 inhibitor
0,171  0,082  Antirickettsial
0,169  0,080  Antineoplastic (bone cancer)
0,094  0,005  5-Alpha-reductase 1 inhibitor
0,141  0,051  Antiviral (Hepatitis B)
0,167  0,077  Liver fibrosis treatment
0,101  0,014  Uterine relaxant
0,118  0,031  Paget's disease treatment
0,092  0,005  Glucocorticoid antagonist
0,113  0,028  Inducible nitric-oxide synthase inhibitor
0,180  0,096  Insulin sensitizer
0,141  0,057  Cyclooxygenase 3 inhibitor
0,147  0,065  Amylase inhibitor
0,126  0,044  AMP-activated protein kinase stimulant
0,151  0,071  Acaricide
0,087  0,007  RNA-directed RNA polymerase stimulant
0,082  0,003  Retinoid X receptor antagonist
0,134  0,055  CC chemokine 6 receptor antagonist
0,101  0,022  HIV-1 integrase (Strand Transfer) inhibitor
0,162  0,084  Male reproductive disfunction treatment
0,083  0,004  Retinoid X gamma receptor agonist
0,095  0,018  CDC25B inhibitor
0,159  0,082  Mutagenic
0,145  0,069  Skeletal muscle relaxant
0,083  0,006  Cholesterol esterase inhibitor
0,081  0,005  Acetyl-CoA transferase 1 inhibitor
0,084  0,009  Acetyl-CoA transferase 2 inhibitor
0,080  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,184  0,109  Antiviral (HIV)
0,079  0,004  Alpha 1L adrenoreceptor agonist
0,119  0,045  Antineoplastic, alkylator
0,165  0,091  Platelet adhesion inhibitor
0,112  0,039  Lanosterol 14 alpha demethylase inhibitor
0,183  0,110  Antineoplastic (lymphoma)
0,077  0,005  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,077  0,005  Farnesoid X receptor agonist
0,083  0,012  Lipocortins synthesis agonist
0,070  0,003  Retinoid X alpha receptor antagonist
0,162  0,096  Wound healing agent
0,134  0,068  Nav1.2 sodium channel blocker
0,070  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,201  0,136  Antiepileptic
0,123  0,058  Microtubule formation inhibitor
0,066  0,004  Retinoic acid receptor antagonist
0,238  0,178  CYP2C9 inhibitor
0,178  0,118  VCAM1 expression inhibitor
0,063  0,004  Retinoic acid alpha receptor antagonist
0,142  0,083  Insulin secretagoues
0,104  0,045  Opioid antagonist
0,060  0,002  Retinoid X beta receptor antagonist
0,102  0,046  Potassium channel activator
0,101  0,046  Antineoplastic antibiotic
0,138  0,083  Genotoxic
0,163  0,110  CYP2B6 inhibitor
0,076  0,024  Hypercalcemia treatment
0,057  0,006  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,061  0,010  Parathyroid hormone antagonist
0,066  0,016  Mineralocorticoid receptor antagonist
0,059  0,010  Retinoic acid alpha receptor agonist
0,110  0,061  Glutathione S-transferase substrate
0,066  0,017  Potassium channel Kv1.3 blocker
0,123  0,075  Acetylcholinesterase inhibitor
0,052  0,003  Retinoid X gamma receptor antagonist
0,054  0,007  Estrone sulfatase inhibitor
0,154  0,107  Phobic disorders treatment
0,074  0,027  Transcription factor AP-1 inhibitor
0,102  0,056  Nitric-oxide synthase inhibitor
0,156  0,111  Psychostimulant
0,051  0,007  ATP citrate lysase inhibitor
0,094  0,051  Antineoplastic alkaloid
0,149  0,106  Diabetic nephropathy treatment
0,081  0,039  Opioid mu receptor antagonist
0,072  0,030  Antimycoplasmal
0,070  0,028  Heat shock protein 90 beta antagonist
0,195  0,153  CYP2D6 inhibitor
0,045  0,003  Retinoic acid beta receptor antagonist
0,106  0,065  DOPA decarboxylase inhibitor
0,045  0,005  Retinoid X beta receptor agonist
0,042  0,003  Retinoic acid receptor gamma antagonist
0,057  0,020  Opioid kappa receptor agonist
0,042  0,004  Thyroid hormone alpha antagonist
0,138  0,100  Movement disorders treatment
0,038  0,003  Thyroid hormone alpha agonist
0,047  0,013  Cholesterol absorption inhibitor
0,037  0,004  NMDA receptor phencyclidine site antagonist
0,097  0,065  Dementia treatment
0,038  0,007  Thyroid hormone agonist
0,094  0,063  Vascular dementia treatment
0,057  0,026  Alpha 1L adrenoreceptor antagonist
0,149  0,118  Interleukin antagonist
0,248  0,218  Alzheimer's disease treatment
0,034  0,005  Retinoic acid gamma receptor agonist
0,095  0,066  Butyrylcholinesterase inhibitor
0,042  0,013  HMG CoA reductase inhibitor
0,175  0,148  Superoxide dismutase inhibitor
0,035  0,008  Retinoic acid receptor agonist
0,064  0,038  TRPA1 antagonist
0,059  0,034  Pregnane X receptor antagonist
0,106  0,082  Beta amyloid protein antagonist
0,065  0,040  Calcium channel P-type blocker
0,206  0,182  GST M1-1 substrate
0,046  0,022  Hypogonadism treatment
0,042  0,018  Glucose-6-phosphate dehydrogenase inhibitor
0,132  0,109  Ca2+-transporting ATPase inhibitor
0,111  0,090  CNS active muscle relaxant
0,158  0,136  Antiamyloidogenic
0,105  0,084  Autism spectrum disorders treatment
0,031  0,011  Hedgehog signaling activator
0,199  0,178  Antithrombotic
0,127  0,107  Acute respiratory distress syndrome (ARDS) treatment
0,081  0,061  Antiprotozoal activity enhancer
0,180  0,160  Renal disease treatment
0,115  0,096  Antineoplastic (squamous cell carcinoma)
0,200  0,182  Vasodilator, coronary
0,144  0,125  Succinate dehydrogenase inhibitor
0,026  0,009  Vitamin D receptor antagonist
0,089  0,072  5-Lipoxygenase inhibitor
0,024  0,009  Retinoic acid beta receptor agonist
0,025  0,010  Corticosteroid-like
0,023  0,009  Progesterone agonist
0,099  0,086  Antitussive
0,065  0,052  Premenstrual syndrome treatment
0,167  0,155  Cardiotonic
0,095  0,083  GABA receptor agonist
0,022  0,010  Progesterone receptor B antagonist
0,040  0,028  Dopamine D5 agonist
0,019  0,008  Telomerase stimulant
0,019  0,008  Glucocorticoid agonist
0,042  0,033  Heme oxygenase inhibitor
0,077  0,068  GABA A receptor agonist
0,036  0,027  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,047  0,039  Cannabinoid CB2 receptor antagonist
0,033  0,027  Tubulin agonist
0,011  0,005  Progesterone receptor A antagonist
0,110  0,104  Interleukin 1 antagonist
0,016  0,013  Vitamin D receptor agonist
0,021  0,018  CYP24 inhibitor
0,006  0,004  Transcortin receptor antagonist
0,100  0,098  Interleukin 8 antagonist
0,086  0,085  Tourette's syndrome treatment
0,011  0,010  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,127  0,126  Dual specificity phosphatase inhibitor

